Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,432.10 23.56 0.14%
S&P 500 1,868.79 3.94 0.21%
NASDAQ 4,105.99 10.48 0.26%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Clay Walker, Country Music Star And Relapsing-Remitting Multiple Sclerosis Patient Urges Others To "Stick With It"



  Clay Walker, Country Music Star And Relapsing-Remitting Multiple Sclerosis
                   Patient Urges Others To "Stick With It"

Walker's Charity, Band Against MS Teams Up with Teva Pharmaceuticals to Launch
Public Service Announcement Campaign and Raise Money for MS Research

PR Newswire

FRAZER, Pa., March 13, 2013

FRAZER, Pa., March 13, 2013 /PRNewswire/ -- Country music singer Clay Walker
today announced the launch of "Stick With It!," a national public service
announcement campaign to educate relapsing-remitting multiple sclerosis (RRMS)
patients about the importance of remaining adherent to a disease management
routine for the long-term. Teva Pharmaceuticals and Band Against MS (BAMS) --
the charity Walker founded a decade ago to help those living with the disease
-- have teamed up for this campaign. The kick-off of "Stick With It!" is in
conjunction with Multiple Sclerosis Awareness Week and will raise money to
fund MS research via the campaign Facebook page
www.facebook.com/stickwithitRRMS.

For every action the public takes to promote awareness, Teva will make a $1
corporate donation for MS research (up to $25,000). Actions include: liking
http://www.facebook.com/StickWithItRRMS or asking the public to share their
favorite "Stick With It!" routine. In addition to supporting a worthy cause,
the public can access tips and helpful information on the site such as
questions to ask the doctor and the importance of adhering to a routine to
manage RRMS.

Research has shown that combining a treatment regimen with lifestyle
management including proper diet and exercise can actually reduce the
frequency of relapses. But clinical studies show that patients who had gaps in
therapy lasting ≥90 days were nearly twice as likely to experience a severe
relapse. 

"The challenge is that in between relapses, patients with RRMS might not have
any apparent symptoms or might even improve. Therefore, patients often 'feel'
better and opt to go off their medication and deviate from the routine that is
working for them," said, Gabriel Pardo, M.D., Director of the OMRF Multiple
Sclerosis Center of Excellence. "This campaign helps to remind patients that
sticking with their routine is the best way to manage their disease, and
encourages those who haven't found what works for them, to work with their
doctor to find a routine that does."

"Stick With It!" reinforces how patient adherence to a management routine that
is working for them is critical to the success of managing RRMS. The public
service announcements will run throughout the year.

"There's a lot of information out there about RRMS, and some of it can be
confusing," says Walker.  "But it's important not to give up -- it took almost
a year of working with my neurologist before I found the routine that worked
best, and now that I have found my groove, I stick with it and encourage
others to do the same."

About Clay Walker
Walker was diagnosed with RRMS, the most common form of MS, in 1996 at the age
of 26 with symptoms that included tingling, numbness and facial spasms. The
diagnosis of this lifelong and unpredictable disease came at a pivotal time in
his life, as he had recently finished recording his fourth album and his
oldest daughter was just born. Over the course of his country music career,
Walker has sold over 11 million albums, has had 11 number one hit singles, and
achieved four Recording Industry Association of America (RIAA) platinum and
two gold certified albums.

About Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis (MS) is a chronic, often disabling disease that attacks the
central nervous system. Symptoms may be mild, such as numbness in the limbs,
or severe, such as paralysis or loss of vision. The progress, severity, and
specific symptoms of MS are unpredictable and vary from one person to another.
In the U.S. today, there are approximately 400,000 people living with MS. In
relapsing-remitting MS, the most common form of the disease, a person
experiences attacks (also called relapses or exacerbations) of worsening
neurologic functioning followed by periods of remission in which partial or
complete recovery occurs.

For more information on the "Stick With It" campaign, please visit
http://www.facebook.com/StickWithItRRMS or http://www.bandagainstms.org.  

About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $20.3 billion in net revenues in 2012.

Media Contact:
Nancy Leone
610.727.6314
nancy.leone@tevapharm.com

SOURCE Teva Pharmaceutical Industries Ltd.

Website: http://www.bandagainstms.org
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement